TiHo Bibliothek elib - Tierärztliche Hochschule Hannover

LITERATURVERZEICHNIS
Depression and epilepsy, pain and psychogenic non-epileptic seizures: clinical and
therapeutic perspectives. Epilepsy Behav. 24: 169-181.
KAST, C., CANFIELD, V., LEVENSON, R., GROS, P., 1996. Transmembrane organization of mouse
P-glycoprotein determined by epitope insertion and immunofluorescence. J Biol Chem.271:
9240-9248.
KERB R., 2006. Review Implications of genetic polymorphisms in drug transporters for
pharmacotherapy. Cancer Lett. 234: 4-33.
KLIEWER, S.A., WILLSON, T.M., 2002. Regulation of xenobiotic and bile acid metabolism by the
nuclear pregnane X receptor. J Lipid Res. 43: 359-364.
KOCH, R., 1884. Die Aetiologie der Tuberkulose. Mitt Kaiser Gesundh 2: 1–88.
KOELLA, W.P., 1986. Tolerance: ist various forms and their nature. In: Frey, H.H., Fröscher, W.,
Koella, W.P. et al., eds. Tolerance to beneficial and adverse effects of antiepileptic drugs. New
York: Raven Press, 1–6.
KÖHLE, C., BOCK, K.W., 2009. Coordinate regulation of human drug-metabolizing enzymes, and
conjugate transporters by the Ah receptor, pregnane X receptor and constitutive androstane
receptor. Biochem. Pharmacol. 77: 689–699.
KÖHLING, R., 2008. Entstehungsmechanismen der Epilepsien - unkonventionelle Hypothesen. Z.
Epileptol. 21: 171-179.
KODAMA, S., NEGISHI, M., 2006. Phenobarbital confers ist diverse effects by activating the orphan
nuclear receptor car. Drug Metab. Rev. 38: 75–87.
KWAN, P., BRODIE, M.J., 2000. Early identification of refractory epilepsy. N. Engl. J. Med. 342: 314-
319.
KWAN, P., BRODIE, M.J., 2010. Definition of refractory epilepsy: defining the indefinable? Lancet
Neurol. 9: 27-29.
KWAN, P., ARZIMANOGLOU, A., BERG, A.T., BRODIE, M.J., HAUSER, W.A., MATHERN, G.,
MOSHE. S.L., PERUCCA, E., WIEBE, S., FRENCH, J., 2010. Definition of drug resistant
epilepsy. Consensus proposal by the ad hoc Task Force of the ILAE Commission on
Therapeutic Strategies Epilepsia 51: 1069-1077.
KWAN, P., SCHACHTER, S.C., BRODIE, M.J., 2011. Drug-resistant epilepsy. N Engl J Med. 365:
919-926.
KUTEYKIN-TEPLYAKOV, K., LUNA-TORTÓS, C., AMBROZIAK, K., LÖSCHER, W., 2010.
Differences in the expression of endogenous efflux transporters in MDR1-transfected versus
wildtype cell lines affect P-glycoprotein mediated drug transport. Br J Pharmacol. 160: 1453-
1463.
LAGAS, J.S., VAN WATERSCHOOT, R.A., VAN TILBURG, V.A., HILLEBRAND, M.J., LANKHEET,
N., ROSING, H., BEIJNEN, J.H., SCHINKEL, A.H., 2009. Brain accumulation of dasatinib is
restricted by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and can
be enhanced by elacridar treatment. Clin Cancer Res. 15: 2344-2351.
191